Navigation Links
Singapore's BIOPOLIS and FUSIONOPOLIS on stage in Boston this week
Date:2/13/2008

Singapores focused transformation into a scientific powerhouse in the biomedical sciences and physical sciences and engineering will stage a presence this week in Boston at the annual meetings of the American Association for the Advancement of Sciences (AAAS) and the Fulbright Academy of Science and Technology.

At the AAAS conference, Singapore scientists will speak at a Friday morning, Feb. 15th symposium on the continuum of cancer research, from the laboratory through clinical and translational research studies with patients.

That afternoon at the Fulbright Academy conference, an expert on Singapores educational system will speak about the school programs that contribute to Singapore pupils top ranking internationally in science and math.

The Asian city-states scientific and educational initiatives under A*STAR (Agency for Science, Technology and Research), established in 2000, will also be showcased at the AAAS meeting. It will highlight Singapores public sector research program, which spans 14 research institutes and several scientific consortia and extramural research with the countrys universities, hospital research centres and other local and international partners.

By participating in the AAAS and the Fulbright Academy annual meetings, we want to strengthen our networks with the international research community to bring about breakthroughs to benefit society. At the same time, this is an excellent opportunity for Singapore to share our experiences in pioneering new directions in scientific education and R&D, said A*STAR Chairman Lim Chuan Poh, who will speak at the Fulbright meeting.

To strengthen Singapores capabilities in the sciences, A*STAR has turned for advice to many of the worlds leaders of science including Nobel laureate and AAAS President David Baltimore. In addition, many other scientists have been recruited to Singapore, full or part-time, to establish new research programs or expand existin
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Moms obesity during conception phase may set the stage for offsprings obesity risk
2. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
3. New light trap captures larval stage of new species; DNA barcode technology used
4. DHS Begins Collecting 10 Fingerprints From International Visitors at Boston Logan International Airport
5. Boston College profs study oxidative stress subcellular to discover its role in diseases
6. Boston University biomedical engineers find chink in bacterias armor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... December 2009 print issue of The FASEB Journal ...r their fertility that women have had since the 19...where androgenic hormones work in the testis to co...This opens a promising avenue for the development ...ope to those who cannot have children because of l...
(Date:11/30/2009)...dioactive gas that is produced by the radioactive ...cay and is found in trace amounts naturally in nea...uilding materials, plants, animals, and the human ... amount of radiation that would be emitted by rado...he units are picocuries per liter (pCi/L). The Ame...
(Date:11/26/2009)...ed deer have been caught in the hunters, sights fo...than decorative. They are lethal weapons that stag...The University of York, UK, has been intrigued by ...century and has become fascinated by the mechanica...laboration with Tomas Landete-Castillejos at the U...
Breaking Biology News(10 mins):Health Physics Society recommends considering action for indoor radon below current guidelines 2Tough yet stiff deer antler is materials scientist's dream 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 1 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 3 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 5 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 6 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 7 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 8 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 9Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4
... written book describes hundreds of well-known and...rporate leaders, and literary greats who used or a...esidents, seven popes, Sir William Osler, J.D. Roc...re among those famous people who were known to hav...ngly is the evidence of Charles Darwins use of hom...
...o the way in which parasites interact with each ot...e likely to break out. , A group of scientists i...r of infectious parasites in rabbits. The findings...ssfully when infectious cyclical diseases in human...niversitys School of Biosciences, University of St...
...ses, such as when to multiply, are often regulated... of interactions between proteins. North Carolina ...y in which a specific protein-protein interaction ... off, leading to uncontrolled cell proliferation ...ished in the December 2007 edition of the Cell Pre...
Other Biology News:The surprising story of Charles Darwin and his homeopathic doctor 2The surprising story of Charles Darwin and his homeopathic doctor 3Can interacting pathogens explain disease patterns? 2Why the switch stays on 2Why the switch stays on 3
(Date:11/27/2009)..., Nov. 27 Cromoz Inc., located in ...e carbon nanotube-based cancer drug delivery syste...notubes, which have functional groups on the walls...s developed in partnership with the Indian Institu...s serves as a drug delivery vehicle with the abili...
(Date:11/26/2009)... new generation of ultrasmall transistors and more...led semiconducting nanowires are closer to reality...ue University and the University of California at ...to create nanowires with layers of different mater... which is a critical requirement for making effici...
(Date:11/25/2009)...ssador to Speak at Economic Club of Canada , ...er 25, 2009 -- Ambassador to Speak at Economic Clu...bassador for International Investment, and Chairma...a biography of David Appia go to www.investinfran...e to meet with press to discuss recent pro-busines...
(Date:11/25/2009)..., Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd...ines, announced today that it executed,a joint ven...Vaccine,Technology Co., Ltd. (Sinovac Dalian). The...ize human-use vaccines. Sinovac will contribute it...rcializing world-class vaccines; the,other party w...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...rta and the National Research Council,s National I... an approach that is leading to improved performan...lls). The development of inexpensive, mass-produce...st for many of the world,s scientists and engineer...ra-high purity silicon and other materials normall...
...ates Anti-Tumor Activity Across Doses and Endpoint... Patients - , , - Data To Be Presented at ASCO,s ...vation to Host Conference Call and Webcast Present...tern Time - , , SAN FRANCISCO, Feb. 25 Medivati...sentation of new efficacy and safety data from an ...
...harmaceuticals Inc.,(Nasdaq: TRBN ) today announ...cent, or 25 employees, and a corporate restructuri...apital markets and the global economy, Trubion,is ...lign its current,resources with its strongest near...for long-term sustainability and success. , Fo...
Other Biology Technology:University of Alberta and NINT researchers make solar energy breakthrough 2Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 5Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring 2Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring 3Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring 4
HyperMu Transposon from EPICENTRE Biotechnologies
Rhesus Macaque IFN-alpha from R&D Systems
Sheep Anti-chk 1 kinase Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Granzyme B ELISpot Kit from R&D Systems
Biology Products: